These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 35026670)
21. Effects of long-term treatment with eicosapentaenoic acid on the heart subjected to ischemia/reperfusion and hypoxia/reoxygenation in rats. Takeo S; Nasa Y; Tanonaka K; Yabe K; Nojiri M; Hayashi M; Sasaki H; Ida K; Yanai K Mol Cell Biochem; 1998 Nov; 188(1-2):199-208. PubMed ID: 9823025 [TBL] [Abstract][Full Text] [Related]
22. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Hu X; Dai S; Wu WJ; Tan W; Zhu X; Mu J; Guo Y; Bolli R; Rokosh G Circulation; 2007 Aug; 116(6):654-63. PubMed ID: 17646584 [TBL] [Abstract][Full Text] [Related]
23. The protective microRNA-199a-5p-mediated unfolded protein response in hypoxic cardiomyocytes is regulated by STAT3 pathway. Zhou Y; Pang B; Xiao Y; Zhou S; He B; Zhang F; Liu W; Peng H; Li P J Physiol Biochem; 2019 Feb; 75(1):73-81. PubMed ID: 30426460 [TBL] [Abstract][Full Text] [Related]
24. Development of an In Vitro Cardiac Ischemic Model Using Primary Human Cardiomyocytes. Hafez P; Chowdhury SR; Jose S; Law JX; Ruszymah BHI; Mohd Ramzisham AR; Ng MH Cardiovasc Eng Technol; 2018 Sep; 9(3):529-538. PubMed ID: 29948837 [TBL] [Abstract][Full Text] [Related]
25. Nicotinamide riboside kinase-2 alleviates ischemia-induced heart failure through P38 signaling. Ahmad F; Tomar D; Aryal A C S; Elmoselhi AB; Thomas M; Elrod JW; Tilley DG; Force T Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165609. PubMed ID: 31743747 [TBL] [Abstract][Full Text] [Related]
26. Human iPSC-engineered cardiac tissue platform faithfully models important cardiac physiology. de Lange WJ; Farrell ET; Kreitzer CR; Jacobs DR; Lang D; Glukhov AV; Ralphe JC Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1670-H1686. PubMed ID: 33606581 [TBL] [Abstract][Full Text] [Related]
27. Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway. Lu Q; Liu J; Li X; Sun X; Zhang J; Ren D; Tong N; Li J Mol Cell Endocrinol; 2020 Feb; 501():110642. PubMed ID: 31759100 [TBL] [Abstract][Full Text] [Related]
28. Can ischemic preconditioning protect against hypoxia-induced damage? Studies of contractile function in isolated perfused rat hearts. Cave AC; Horowitz GL; Apstein CS J Mol Cell Cardiol; 1994 Nov; 26(11):1471-86. PubMed ID: 7897671 [TBL] [Abstract][Full Text] [Related]
29. Low-dose taurine upregulates taurine transporter expression in acute myocardial ischemia. Zhang Y; Yang L; Yang YJ; Liu XY; Jia JG; Qian JY; Wang KQ; Zuo J; Ge JB Int J Mol Med; 2013 Apr; 31(4):817-24. PubMed ID: 23381576 [TBL] [Abstract][Full Text] [Related]
30. [Paclitaxel enhances the protective effect of myocardial ischemia preconditioning on ischemia/reperfusion injury in aged rat]. Guo H; Zheng M; Jiao YB; Zheng H Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Sep; 46(9):719-724. PubMed ID: 30293379 [No Abstract] [Full Text] [Related]
31. Conditioned medium from adipose-derived stem cells attenuates ischemia/reperfusion-induced cardiac injury through the microRNA-221/222/PUMA/ETS-1 pathway. Lee TL; Lai TC; Lin SR; Lin SW; Chen YC; Pu CM; Lee IT; Tsai JS; Lee CW; Chen YL Theranostics; 2021; 11(7):3131-3149. PubMed ID: 33537078 [No Abstract] [Full Text] [Related]
33. Upregulated ATF6 contributes to chronic intermittent hypoxia-afforded protection against myocardial ischemia/reperfusion injury. Jia W; Jian Z; Li J; Luo L; Zhao L; Zhou Y; Tang F; Xiao Y Int J Mol Med; 2016 May; 37(5):1199-208. PubMed ID: 27035093 [TBL] [Abstract][Full Text] [Related]
34. A 3-D human model of complex cardiac arrhythmias. Williams K; Liang T; Massé S; Khan S; Hatkar R; Keller G; Nanthakumar K; Nunes SS Acta Biomater; 2021 Sep; 132():149-161. PubMed ID: 33713861 [TBL] [Abstract][Full Text] [Related]
35. Transcription-independent Induction of ERBB1 through Hypoxia-inducible Factor 2A Provides Cardioprotection during Ischemia and Reperfusion. Lee JW; Koeppen M; Seo SW; Bowser JL; Yuan X; Li J; Sibilia M; Ambardekar AV; Zhang X; Eckle T; Yoo SH; Eltzschig HK Anesthesiology; 2020 Apr; 132(4):763-780. PubMed ID: 31794514 [TBL] [Abstract][Full Text] [Related]
36. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation. Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729 [TBL] [Abstract][Full Text] [Related]
37. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. Graham RM; Frazier DP; Thompson JW; Haliko S; Li H; Wasserlauf BJ; Spiga MG; Bishopric NH; Webster KA J Exp Biol; 2004 Aug; 207(Pt 18):3189-200. PubMed ID: 15299040 [TBL] [Abstract][Full Text] [Related]
38. ZFP580, a novel zinc-finger transcription factor, is involved in cardioprotection of intermittent high-altitude hypoxia against myocardial ischemia-reperfusion injury. Meng XY; Yu HL; Zhang WC; Wang TH; Mai X; Liu HT; Xu RC PLoS One; 2014; 9(4):e94635. PubMed ID: 24722354 [TBL] [Abstract][Full Text] [Related]
40. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway. Wu L; Tan JL; Wang ZH; Chen YX; Gao L; Liu JL; Shi YH; Endoh M; Yang HT J Mol Cell Cardiol; 2015 Apr; 81():150-61. PubMed ID: 25731682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]